Lee Hae-Young, Burkard Thilo
Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
Medical Outpatient and Hypertension Clinic, ESH Hypertension Centre of Excellence, University Hospital Basel, Basel, Switzerland.
Korean Circ J. 2022 Mar;52(3):198-204. doi: 10.4070/kcj.2021.0405.
Blood pressure measurement (BPM) is an essential part of medical examination, and therefore accuracy of BPM devices is crucial. Over the past few years, there has been a rise in new BPM techniques using photoplethysmographic (PPG) signals and complex algorithms for blood pressure estimation. Especially the combination of a mobile device or a smartphone with a camera using PPG may potentially revolutionize BPM in the future. The first-ever BPM application to be approved as a medical device was one by the Korean Ministry of Food and Drug Safety in 2020, despite the lack of robust scientific evidence proving its validity. While the prospect of using these novel BPM devices is an opportunity, there are also some critical issues around calibration and utility in different patient groups that need to be resolved before they can be incorporated into daily clinical practice.
血压测量(BPM)是医学检查的重要组成部分,因此BPM设备的准确性至关重要。在过去几年中,使用光电容积脉搏波描记法(PPG)信号和复杂算法进行血压估计的新型BPM技术不断涌现。特别是将移动设备或智能手机与使用PPG的摄像头相结合,可能会在未来彻底改变BPM。有史以来第一个被批准为医疗设备的BPM应用程序是韩国食品药品安全部在2020年批准的,尽管缺乏有力的科学证据证明其有效性。虽然使用这些新型BPM设备的前景是一个机遇,但在将它们纳入日常临床实践之前,还需要解决一些关于不同患者群体的校准和实用性的关键问题。